Norgine websites Contact us Home About Norgine Partnering Responsibility Products Careers Media Transparency and public declarations Patient Organisations Please see below a list of all patient organisations to which Norgine provided financial support and/or significant indirect/non-financial support or engaged for contracted services. Included in this list are staff fund raising events and donations as well as descriptions of the nature of the support/contracted services which should enable the reader to understand the significance of the support that the patient organisation received, as well as the monetary value of the support. Norgine’s interactions and support to Patient Organisations Methodology Notes 2021 Transparency declaration (2020 data) 2020 Transparency declaration (2019 data) 2019 Transparency declaration (2018 data) Medicinal Products Transparency Disclosure Healthcare Professionals and Organisations In line with the EFPIA Code of Practice and various country Disclosure Codes and legal requirements for transparency, Norgine is disclosing its interactions and relevant transfers of value with healthcare professionals and healthcare organisations. This information includes the support to healthcare organisations in the form of donations and grants, as well as benefits in kind and sponsorship agreements to manage an event. It also covers the support to healthcare professionals with contributions to cost of events, including registration fees, travel and accommodation, as well as service and consultancy fees and related expenses that may arise. Transfers of value associated with Research and Development are also provided. Norgine also publishes information from Australia and New Zealand. Please click on the relevant country icon to view the information related to medicinal products: If a flag for a particular European country is not displayed below, Norgine has not had interactions or transfers of value data to report for that country over the last 3 years. Please also note that Norgine works with third parties in some countries and it is the responsibility of the third party to report any qualifying interactions publicly. AUSTRALIA AUSTRIA BELGIUM DENMARK EIRE FINLAND FRANCE GERMANY ITALY NETHERLANDS NEW ZEALAND NORWAY POLAND PORTUGAL SPAIN SWEDEN SWITZERLAND AND LIECHTENSTEIN UNITED KINGDOM Medical Devices Transparency Disclosure Healthcare Organisations In line with the MedTech Code of Practice, Norgine is publishing its interactions and relevant transfers of value with European healthcare organisations, in terms of educational grants. This information typically includes educational grants to healthcare organisations in the form of support to third party organised events, healthcare professionals participation at third party organised educational events, scholarship, fellowship and grants for public awareness campaigns. Please note that direct sponsorship to healthcare professionals is not allowed. Click below to view the information related to Medical Devices: 2019 Medical Device Transparency Declaration (2018 data) 2020 Medical Device Transparency Declaration (2019 data) 2021 Medical Device Transparency Declaration (2020 data) Collaborative Working with Organisations Norgine is involved in collaborative working projects which either enhances patient care or are for the benefit of patients, or alternatively benefits the Health Services (e.g. NHS in UK) and, as a minimum, maintains patient care. Find out more about these projects by reading the executive summaries below. United Kingdom Patient Information Forum – Being Induced Survey – Executive Summary Terms of Use Privacy Policy Cookie Policy Legal Entities Employee Portal Norgine B.V. Antonio Vivaldistraat 150, 1083HP Amsterdam, Nederland Tel: +31 (0)20 567 09 00 Fax: +31 (0)20 567 09 99 Handelsregister: AMSTERDAM 30127007 www.norgine.com © Norgine 2020 All product names mentioned in this website are trademarks owned by or licensed to the Norgine group of companies, unless otherwise noted.